Search for a report

NORTH AMERICA BIOCHIPS MARKET FORECAST 2019-2028

  • You are here:
  • Home
  • Downloads
  • NORTH AMERICA BIOCHIPS MARKET FORECAST 2019-2028

NORTH AMERICA BIOCHIPS MARKET FORECAST 2019-2028

The North America biochips market is anticipated to project a CAGR of 13.65% over the forecast period of 2019-2028. The increasing awareness about biochips and their widespread application in different fields, rapid acceptance of innovative technologies, and the presence of an enhanced healthcare system are some of the predominating factors driving market growth in the region.

NORTH AMERICA BIOCHIPS MARKET FORECAST 2019-2028

North America Biochips Market By Type (DNA Chips, Lab On A Chip, Protein Chips, Other Chips) By Substrate Materials (glass, Polymers, Silicon & Other Substrate Materials) By End Users (Biotechnology And Pharmaceutical Companies, Hospitals And Diagnostics Centers, Academic And Research Institute) By Geography.

Request free sample

The North America biochips market is anticipated to project a CAGR of 13.65% over the forecast period of 2019-2028. The increasing awareness about biochips and their widespread application in different fields, rapid acceptance of innovative technologies, and the presence of an enhanced healthcare system are some of the predominating factors driving market growth in the region.
North America Biochips Market

To know more about this report, request a free sample copy.

In order to assess the North America biochips market growth, the region is segmented into the United States and Canada. The United States dominated the North America market in 2019, owing to the growing prevalence of cancer and other chronic diseases, and the presence of a large number of patients opting for personalized medications. In 2018, the US healthcare sector accounted for 17.9% of the country’s GDP. The US has been a major center for all the recent developments in the field of medicine. The HTS screening technologies within academic research increased drastically in the US. Moreover, the HHS declared the allocation of funds to enhance microfluidic platforms for blood testing, among neonatal and pediatric patients. The field of point-of-care diagnostics widely uses microfluidic technology for various applications like infectious and chronic diseases, molecular diagnostics in a resource-limited setting.  Moreover, the United States FDA, NIH, and DARPA are together investing significantly in funding research to enhance the development of the chips used in testing the effects of chemical and radiation exposure on humans, which further boots market growth in the region. Additionally, a number of medical device companies such as Johnson & Johnson, Medtronic, etc. are anticipated to augment the R&D budgets by nearly 3%, which will boost the R&D expenditure for biochip, and hence drive market growth.

Abbott Laboratories, headquartered in Abbott Park, Illinois, the US, is a pharmaceutical company that develops, manufactures, and markets a broad line of healthcare products. In June 2019, the company acquired GLP Systems GmbH in Hamburg, Germany.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
    3. MARKET DYNAMICS
      • PARENT MARKET ANALYSIS: GENOMICS AND PROTEOMICS MARKET
      • DEVELOPMENT OF BIOCHIPS
      • MARKET DEFINITION
      •    KEY DRIVERS
        • RISING INCIDENCES OF CHRONIC DISEASES
        • GROWING INTEREST IN PERSONALIZED MEDICINES
        • APPLICATION OF PROTEOMICS AND GENOMICS IN CANCER RESEARCH
        • RAPIDLY GROWING USE OF POINT-OF-CARE TESTING DIAGNOSTICS
      •    KEY RESTRAINTS
        • HIGH INSTRUMENTATION COST
        • LACK OF AWARENESS AMONG COMMON PEOPLE ABOUT BIOCHIP TECHNOLOGY
        • AVAILABILITY OF ALTERNATIVE TECHNOLOGY: NEXT GENERATION SEQUENCING (NGS) TECHNOLOGY
        • COMPLEXITY OF BIOLOGICAL SYSTEMS
        • LACK OF COMMON REGULATORY STANDARDS
    1. KEY ANALYTICS
      • IMPACT OF COVID-19 ON BIOCHIPS
      • KEY INVESTMENT INSIGHTS
      •    PORTER’S FIVE FORCE ANALYSIS
        • BUYER POWER
        • SUPPLIER POWER
        • SUBSTITUTION
        • NEW ENTRANTS
        • INDUSTRY RIVALRY
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
      •    VALUE CHAIN ANALYSIS
        • RESEARCH & DEVELOPMENT
        • RAW MATERIALS
        • MANUFACTURING
        • WHOLESALERS/RETAILERS/DISTRIBUTORS
        • END-USER
      •    KEY BUYING CRITERIA
        • COST
        • APPLICATIONS
        • PRODUCT TYPE
      • REGULATORY FRAMEWORK
    2. MARKET BY TYPE
      •    DNA CHIPS
        • AGRICULTURAL BIOTECHNOLOGY
        • CANCER DIAGNOSIS & TREATMENT
        • DRUG DISCOVERY
        • GENE EXPRESSION
        • GENOMICS
        • SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING
        • OTHER DNA CHIPS
      •    LAB ON A CHIP
        • CLINICAL DIAGNOSTICS
        • DRUG DISCOVERY
        • GENOMICS
        • POINT OF CARE & IN VITRO DIAGNOSIS
        • PROTEOMICS
        • OTHER LAB ON A CHIP
      •    PROTEIN CHIPS
        • DIAGNOSTICS
        • DRUG DISCOVERY
        • EXPRESSION PROFILING
        • HIGH THROUGHPUT SCREENING
        • PROTEOMICS
        • OTHER PROTEIN CHIPS
      •    OTHER TYPES
        • CELL ARRAYS
        • TISSUE ARRAYS
    1. MARKET BY SUBSTRATE MATERIALS
      • GLASS
      • POLYMERS
      • SILICON
      • OTHER SUBSTRATE MATERIALS
    2. MARKET BY END-USER
      • BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES
      • HOSPITALS AND DIAGNOSTICS CENTERS
      • ACADEMIC AND RESEARCH INSTITUTES
    3. GEOGRAPHICAL ANALYSIS
      •    NORTH AMERICA
        • UNITED STATES
        • CANADA
    1. COMPANY PROFILES
      • ABBOTT LABORATORIES INC
      • AGILENT TECHNOLOGIES INC
      • BIOCHAIN INSTITUTE INC
      • BIOMÉRIEUX SA
      • BIO-RAD LABORATORIES INC
      • CEPHEID
      • CYBRDI INC
      • F HOFFMANN-LA ROCHE LTD
      • FLUIDIGM CORPORATION
      • GE HEALTHCARE
      • ILLUMINA INC
      • MERCK KGAA
      • PERKINELMER INC
      • RANDOX LABORATORIES LTD
      • THERMO FISHER SCIENTIFIC INC

    LIST OF TABLES

    TABLE 1: MARKET SNAPSHOT – BIOCHIPS

    TABLE 2: ESTIMATED NUMBER OF NEW CANCER CASES & ESTIMATED DEATHS DUE TO CANCER IN 2018

    TABLE 3: REGULATORY FRAMEWORK

    TABLE 4: NORTH AMERICA BIOCHIPS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

    TABLE 5: NORTH AMERICA BIOCHIPS MARKET, BY TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)

    TABLE 6: NORTH AMERICA BIOCHIPS MARKET, BY DNA CHIPS, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

    TABLE 7: NORTH AMERICA BIOCHIPS MARKET, BY DNA CHIPS, FORECAST YEARS, 2019-2028 (IN $ MILLION)

    TABLE 8: NORTH AMERICA BIOCHIPS MARKET, BY LAB ON A CHIP, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

    TABLE 9: NORTH AMERICA BIOCHIPS MARKET, BY LAB ON A CHIP, FORECAST YEARS, 2019-2028 (IN $ MILLION)

    TABLE 10: NORTH AMERICA BIOCHIPS MARKET, BY PROTEIN CHIPS, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

    TABLE 11: NORTH AMERICA BIOCHIPS MARKET, BY PROTEIN CHIPS, FORECAST YEARS, 2019-2028 (IN $ MILLION)

    TABLE 12: NORTH AMERICA BIOCHIPS MARKET, BY OTHER TYPES, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

    TABLE 13: NORTH AMERICA BIOCHIPS MARKET, BY OTHER TYPES, FORECAST YEARS, 2019-2028 (IN $ MILLION)

    TABLE 14: PROPERTIES OF BIOCHIPS SUBSTRATE MATERIALS

    TABLE 15: NORTH AMERICA BIOCHIPS MARKET, BY SUBSTRATE MATERIALS, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

    TABLE 16: NORTH AMERICA BIOCHIPS MARKET, BY SUBSTRATE MATERIALS, FORECAST YEARS, 2019-2028 (IN $ MILLION)

    TABLE 17: NORTH AMERICA BIOCHIPS MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

    TABLE 18: NORTH AMERICA BIOCHIPS MARKET, BY END-USER, FORECAST YEARS, 2019-2028 (IN $ MILLION)

    TABLE 19: NORTH AMERICA BIOCHIPS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

    TABLE 20: NORTH AMERICA BIOCHIPS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

    LIST OF FIGURES

    FIGURE 1: DEVELOPMENT OF BIOCHIPS

    FIGURE 2: KEY INVESTMENT INSIGHTS

    FIGURE 3: PORTER’S FIVE FORCE ANALYSIS

    FIGURE 4: OPPORTUNITY MATRIX

    FIGURE 5: VENDOR LANDSCAPE

    FIGURE 6: VALUE CHAIN ANALYSIS

    FIGURE 7: KEY BUYING CRITERIA

    FIGURE 8: NORTH AMERICA BIOCHIPS MARKET, GROWTH POTENTIAL, BY TYPE, IN 2019

    FIGURE 9: NORTH AMERICA BIOCHIPS MARKET, BY DNA CHIPS, 2019-2028 (IN $ MILLION)

    FIGURE 10: NORTH AMERICA BIOCHIPS MARKET, GROWTH POTENTIAL, BY DNA CHIPS, IN 2019

    FIGURE 11: NORTH AMERICA BIOCHIPS MARKET, BY AGRICULTURAL BIOTECHNOLOGY, 2019-2028 (IN $ MILLION)

    FIGURE 12: NORTH AMERICA BIOCHIPS MARKET, BY CANCER DIAGNOSIS & TREATMENT, 2019-2028 (IN $ MILLION)

    FIGURE 13: NORTH AMERICA BIOCHIPS MARKET, BY DRUG DISCOVERY, 2019-2028 (IN $ MILLION)

    FIGURE 14: NORTH AMERICA BIOCHIPS MARKET, BY GENE EXPRESSION, 2019-2028 (IN $ MILLION)

    FIGURE 15: NORTH AMERICA BIOCHIPS MARKET, BY GENOMICS, 2019-2028 (IN $ MILLION)

    FIGURE 16: NORTH AMERICA BIOCHIPS MARKET, BY SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING, 2019-2028 (IN $ MILLION)

    FIGURE 17: NORTH AMERICA BIOCHIPS MARKET, BY OTHER DNA CHIPS, 2019-2028 (IN $ MILLION)

    FIGURE 18: NORTH AMERICA BIOCHIPS MARKET, BY LAB ON A CHIP, 2019-2028 (IN $ MILLION)

    FIGURE 19: NORTH AMERICA BIOCHIPS MARKET, GROWTH POTENTIAL, BY LAB ON A CHIP, IN 2019

    FIGURE 20: NORTH AMERICA BIOCHIPS MARKET, BY CLINICAL DIAGNOSTICS, 2019-2028 (IN $ MILLION)

    FIGURE 21: NORTH AMERICA BIOCHIPS MARKET, BY DRUG DISCOVERY, 2019-2028 (IN $ MILLION)

    FIGURE 22: NORTH AMERICA BIOCHIPS MARKET, BY GENOMICS, 2019-2028 (IN $ MILLION)

    FIGURE 23: NORTH AMERICA BIOCHIPS MARKET, BY POINT OF CARE & IN VITRO DIAGNOSIS, 2019-2028 (IN $ MILLION)

    FIGURE 24: NORTH AMERICA BIOCHIPS MARKET, BY PROTEOMICS, 2019-2028 (IN $ MILLION)

    FIGURE 25: NORTH AMERICA BIOCHIPS MARKET, BY OTHER LAB ON A CHIP, 2019-2028 (IN $ MILLION)

    FIGURE 26: NORTH AMERICA BIOCHIPS MARKET, BY PROTEIN CHIPS, 2019-2028 (IN $ MILLION)

    FIGURE 27: NORTH AMERICA BIOCHIPS MARKET, GROWTH POTENTIAL, BY PROTEIN CHIPS, IN 2019

    FIGURE 28: NORTH AMERICA BIOCHIPS MARKET, BY DIAGNOSTICS, 2019-2028 (IN $ MILLION)

    FIGURE 29: NORTH AMERICA BIOCHIPS MARKET, BY DRUG DISCOVERY, 2019-2028 (IN $ MILLION)

    FIGURE 30: NORTH AMERICA BIOCHIPS MARKET, BY EXPRESSION PROFILING, 2019-2028 (IN $ MILLION)

    FIGURE 31: NORTH AMERICA BIOCHIPS MARKET, BY HIGH THROUGHPUT SCREENING, 2019-2028 (IN $ MILLION)

    FIGURE 32: NORTH AMERICA BIOCHIPS MARKET, BY PROTEOMICS, 2019-2028 (IN $ MILLION)

    FIGURE 33: NORTH AMERICA BIOCHIPS MARKET, BY OTHER PROTEIN CHIPS, 2019-2028 (IN $ MILLION)

    FIGURE 34: NORTH AMERICA BIOCHIPS MARKET, BY OTHER TYPES, 2019-2028 (IN $ MILLION)

    FIGURE 35: NORTH AMERICA BIOCHIPS MARKET, GROWTH POTENTIAL, BY OTHER TYPES, IN 2019

    FIGURE 36: NORTH AMERICA BIOCHIPS MARKET, BY CELL ARRAYS, 2019-2028 (IN $ MILLION)

    FIGURE 37: NORTH AMERICA BIOCHIPS MARKET, BY TISSUE ARRAYS, 2019-2028 (IN $ MILLION)

    FIGURE 38: NORTH AMERICA BIOCHIPS MARKET, GROWTH POTENTIAL, BY SUBSTRATE MATERIALS, IN 2019

    FIGURE 39: NORTH AMERICA BIOCHIPS MARKET, BY GLASS, 2019-2028 (IN $ MILLION)

    FIGURE 40: NORTH AMERICA BIOCHIPS MARKET, BY POLYMERS, 2019-2028 (IN $ MILLION)

    FIGURE 41: NORTH AMERICA BIOCHIPS MARKET, BY SILICON, 2019-2028 (IN $ MILLION)

    FIGURE 42: NORTH AMERICA BIOCHIPS MARKET, BY OTHER SUBSTRATE MATERIALS, 2019-2028 (IN $ MILLION)

    FIGURE 43: NORTH AMERICA BIOCHIPS MARKET, GROWTH POTENTIAL, BY END-USER, IN 2019

    FIGURE 44: NORTH AMERICA BIOCHIPS MARKET, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, 2019-2028 (IN $ MILLION)

    FIGURE 45: NORTH AMERICA BIOCHIPS MARKET, BY HOSPITALS AND DIAGNOSTICS CENTERS, 2019-2028 (IN $ MILLION)

    FIGURE 46: NORTH AMERICA BIOCHIPS MARKET, BY ACADEMIC AND RESEARCH INSTITUTES, 2019-2028 (IN $ MILLION)

    FIGURE 47: NORTH AMERICA BIOCHIPS MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)

    FIGURE 48: UNITED STATES BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)

    FIGURE 49: CANADA BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)

    1. GEOGRAPHICAL ANALYSIS
      • NORTH AMERICA
        • UNITED STATES
        • CANADA
    1. MARKET BY TYPE
      •    DNA CHIPS
        • AGRICULTURAL BIOTECHNOLOGY
        • CANCER DIAGNOSIS & TREATMENT
        • DRUG DISCOVERY
        • GENE EXPRESSION
        • GENOMICS
        • SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING
        • OTHER DNA CHIPS
      •    LAB ON A CHIP
        • CLINICAL DIAGNOSTICS
        • DRUG DISCOVERY
        • GENOMICS
        • POINT OF CARE & IN VITRO DIAGNOSIS
        • PROTEOMICS
        • OTHER LAB ON A CHIP
      •    PROTEIN CHIPS
        • DIAGNOSTICS
        • DRUG DISCOVERY
        • EXPRESSION PROFILING
        • HIGH THROUGHPUT SCREENING
        • PROTEOMICS
        • OTHER PROTEIN CHIPS
      •    OTHER TYPES
        • CELL ARRAYS
        • TISSUE ARRAYS
    1. MARKET BY SUBSTRATE MATERIALS
      • GLASS
      • POLYMERS
      • SILICON
      • OTHER SUBSTRATE MATERIALS
    2. MARKET BY END-USER
      • BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES
      • HOSPITALS AND DIAGNOSTICS CENTERS
      • ACADEMIC AND RESEARCH INSTITUTES

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


      Choose License Type

      Buy Now